DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Nonhematopoietic erythropoietin derivative protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis
Author:
Affiliation:

Fund Project:

This study was supported by jiangsu Provincial Science Foundation of China(BK2006229)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    Abstract:

    Objective:Carbamylated EPO(CEPO) is a derivative of erythropoietin(EPO) by subjecting it to carbamylation. It does not stimulate erythropoiesis, but effectively protects tissue from injury. The present study was to investigate the effect of CEPO treatment using in vitro models of hypoxia/reoxygenation(H/R). Methods:Cardiomyocytes were exposed to hypoxia(95% N2 and 5% CO2) for 1 hour followed by 4 hours of reoxygenation(95% O2 and 5% CO2). CEPO was administered after hypoxia, just before reoxygenation. The apoptotic cardiomyocytes were determined by flow cytometry. The level of protein was assessed by western blot analysis. Results: CEPO treatment significantly decreased the apoptotic cardiomyocytes by 54.20% compared with H/R group. Western blot analysis showed that CEPO administration increased the level of Bcl-2(an antiapoptotic protein) by 62.22% compared with H/R group. Conclusion: Acute administration of CEPO protected cardiomyocytes from H/R-induced apoptosis. CEPO protected cardiomyocytes with a concomitant upregulation of Bcl-2 after H/R injury.

    参考文献
    相似文献
    引证文献
引用本文

Xuan Xu, Xiaohong Shan, Zhijuan Cao, Meiling Wu, Qi Chen, Yuehua Li.[J].南京医科大学学报(自然科学版),2008,28(2):71-74

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2008-03-04
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明